Olfr518, an olfactory receptor belonging to the G protein-coupled receptor (GPCR) family, plays a crucial role in the intricate process of olfaction. Positioned in the sensory neurons of the olfactory epithelium, Olfr518 is instrumental in detecting specific odorants, initiating a cascade of signaling events that lead to the perception of smell. As a GPCR, Olfr518 transduces extracellular signals into intracellular responses, activating downstream signaling pathways involved in olfactory signal transduction. The receptor is intricately connected to various signaling cascades, including GPCR, TGF-β, PI3K-Akt, MAPK, and mTOR pathways, underscoring its role in mediating diverse intracellular responses to external olfactory stimuli.
The inhibition of Olfr518 involves a sophisticated interplay of chemical inhibitors targeting key components of these signaling pathways. These inhibitors, by disrupting or modulating specific proteins within the pathways, indirectly influence Olfr518 expression. For instance, inhibitors acting on GPCR signaling cascades disrupt the intricate signaling events downstream of Olfr518, while those targeting TGF-β receptors or components of the PI3K-Akt pathway impact the receptor through intricate cross-talk mechanisms. Similarly, inhibitors of MEK in the MAPK pathway or mTOR in the mTOR pathway exert indirect inhibitory effects on Olfr518 by interfering with the intricate signaling network associated with olfactory perception. The effectiveness of these inhibitors lies in their ability to perturb the finely tuned balance of signaling events, resulting in altered expression levels of Olfr518 and, consequently, influencing olfactory signal transduction. In conclusion, Olfr518 stands as a key player in the complex orchestration of olfactory perception, with its inhibition being intricately linked to the disruption of multiple signaling pathways. The diverse range of chemical inhibitors identified reflects the intricate nature of olfactory signal transduction and the need for nuanced approaches to modulate Olfr518 expression. Understanding these mechanisms sheds light on the complex regulatory networks governing olfactory receptor function, providing valuable insights for further exploration in the field of olfaction research.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A disrupts the GPCR signaling cascades associated with Olfr518 by interfering with downstream cAMP production. This disrupts the olfactory signaling pathway, indirectly inhibiting Olfr518. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 acts as a TGF-β receptor inhibitor, impacting the TGF-β signaling pathway. By modulating this pathway, it indirectly influences Olfr518 expression, serving as an indirect inhibitor. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, a key player in the PI3K-Akt signaling pathway. By disrupting this pathway, Wortmannin indirectly affects Olfr518 expression, acting as an indirect inhibitor. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK, a component of the MAPK signaling pathway. Its action on this pathway indirectly influences Olfr518 expression, serving as an indirect inhibitor of the target protein. | ||||||
JNK Inhibitor VIII | 894804-07-0 | sc-202673 | 5 mg | $272.00 | 2 | |
JNK Inhibitor VIII disrupts the JNK signaling pathway, indirectly impacting Olfr518 expression. This indirect inhibition is mediated through the modulation of the c-Jun N-terminal kinase pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a crucial protein in the mTOR signaling pathway. By affecting this pathway, Rapamycin indirectly influences Olfr518 expression, serving as an indirect inhibitor. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, affecting the PI3K-Akt signaling pathway. Its impact on this pathway indirectly leads to Olfr518 inhibition, serving as an indirect inhibitor of the olfactory receptor. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, an upstream regulator in the MAPK signaling pathway. By disrupting this pathway, PD98059 indirectly influences Olfr518 expression, serving as an indirect inhibitor. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, disrupting the JNK signaling pathway. Its action on this pathway indirectly affects Olfr518 expression, acting as an indirect inhibitor of the target olfactory receptor. | ||||||
LY 364947 | 396129-53-6 | sc-203122 sc-203122A | 5 mg 10 mg | $107.00 $156.00 | 4 | |
LY364947 functions as a TGF-β receptor inhibitor, impacting the TGF-β signaling pathway. By modulating this pathway, it indirectly influences Olfr518 expression, serving as an indirect inhibitor. | ||||||